Amicus Therapeutics, Inc.
FOLDDelisted Apr 27, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001178879
Amicus Therapeutics, Inc. was delisted on Apr 27, 2026; its insiders filed their last Form 4 on Apr 27, 2026; 298 institutions reported holding it in 13F filings for Q1 2026, worth $4.81B in total; Soros Fund Management was the only superinvestor holding it.
Superinvestors holding FOLD, Q1 2026
1 superinvestor reports holding Amicus Therapeutics, Inc. on Form 13F, worth $83.2M in total. Weight is Amicus Therapeutics, Inc.'s share of each 13F portfolio; actions compare shares with Q4 2025.
| Superinvestor | % of portfolio | Shares | Value | vs. previous quarter |
|---|---|---|---|---|
| Soros Fund ManagementGeorge Soros | 1.1% | 5,753,186 | $83.2M | Added+15.1% |
Moves by quarter
Superinvestors that opened, added to, trimmed or sold out of FOLD each quarter, comparing shares with the quarter before. A superinvestor that didn't file for a quarter isn't listed, and isn't counted as selling.
Q1 2026
1 superinvestor holding at quarter end
- Added
- Soros Fund Management (+15.1%)
Q4 2025
1 superinvestor holding at quarter end
Q3 2021
0 superinvestors holding at quarter end
- Sold out
- Maverick Capital
Q2 2021
1 superinvestor holding at quarter end
- Reduced
- Maverick Capital (−33.3%)